Float Short %

22.89

Margin Of Safety %

Put/Call OI Ratio

1.25

EPS Next Q Diff

0.37

EPS Last/This Y

0.26

EPS This/Next Y

0.69

Price

7.2

Target Price

18.83

Analyst Recom

1.29

Performance Q

-29.37

Relative Volume

0.53

Beta

1.09

Ticker: EOLS

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	EOLS	6.72	1.13	1.06	20824
2025-08-18	EOLS	6.7	1.23	0.00	19047
2025-08-19	EOLS	7.14	1.23	0.07	19048
2025-08-20	EOLS	7.24	1.24	0.32	19029
2025-08-21	EOLS	7.43	1.23	0.14	19045
2025-08-22	EOLS	7.68	1.24	0.08	19028
2025-08-25	EOLS	7.41	1.25	0.11	18973
2025-08-26	EOLS	7.66	1.25	0.12	18940
2025-08-27	EOLS	7.57	1.25	0.14	18963
2025-08-28	EOLS	7.51	1.25	1.25	18992
2025-08-29	EOLS	7.64	1.25	0.00	19021
2025-09-02	EOLS	7.51	1.26	0.36	18951
2025-09-03	EOLS	7.39	1.26	0.71	18945
2025-09-04	EOLS	7.53	1.26	0.32	18945
2025-09-05	EOLS	7.68	1.27	0.00	18935
2025-09-08	EOLS	7.62	1.27	0.37	18939
2025-09-09	EOLS	7.41	1.25	0.50	19071
2025-09-10	EOLS	7.35	1.25	0.01	19075
2025-09-11	EOLS	7.51	1.25	0.04	19040
2025-09-12	EOLS	7.2	1.25	0.01	19089
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	EOLS	6.72	12.3	11.2	-0.55
2025-08-18	EOLS	6.70	12.3	12.5	-0.55
2025-08-19	EOLS	7.13	12.3	10.9	-0.55
2025-08-20	EOLS	7.24	12.3	12.0	-0.55
2025-08-21	EOLS	7.43	12.3	11.7	-0.55
2025-08-22	EOLS	7.69	12.3	11.5	-0.55
2025-08-25	EOLS	7.41	12.3	13.2	-0.55
2025-08-26	EOLS	7.65	12.3	11.7	-0.55
2025-08-27	EOLS	7.58	12.3	12.6	-0.55
2025-08-28	EOLS	7.51	12.3	12.6	-0.55
2025-08-29	EOLS	7.63	12.3	12.0	-0.55
2025-09-02	EOLS	7.51	12.3	12.7	-0.55
2025-09-03	EOLS	7.38	12.3	62.0	-0.55
2025-09-04	EOLS	7.53	12.3	62.7	-0.55
2025-09-05	EOLS	7.66	12.3	62.7	-0.55
2025-09-08	EOLS	7.61	12.3	62.2	-0.55
2025-09-09	EOLS	7.41	12.3	61.8	-0.55
2025-09-10	EOLS	7.34	12.3	62.2	-0.55
2025-09-11	EOLS	7.51	12.3	62.7	-0.55
2025-09-12	EOLS	7.20	12.3	61.6	-0.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	EOLS	-3.83	4.41	23.56
2025-08-18	EOLS	-3.46	3.43	24.63
2025-08-19	EOLS	-2.62	3.43	24.63
2025-08-20	EOLS	-2.62	3.43	24.63
2025-08-21	EOLS	-2.62	3.43	24.63
2025-08-22	EOLS	-2.62	3.43	24.63
2025-08-25	EOLS	-2.62	8.60	26.68
2025-08-26	EOLS	-1.85	8.60	26.68
2025-08-27	EOLS	-1.89	8.60	21.15
2025-08-28	EOLS	-1.89	8.60	21.15
2025-08-29	EOLS	-1.89	8.60	21.15
2025-09-02	EOLS	-1.89	8.06	21.02
2025-09-03	EOLS	-1.93	8.06	21.02
2025-09-04	EOLS	-1.93	8.06	21.02
2025-09-05	EOLS	-1.93	8.06	21.02
2025-09-08	EOLS	-1.93	9.35	21.02
2025-09-09	EOLS	-1.93	9.35	21.02
2025-09-10	EOLS	-1.93	9.35	21.02
2025-09-11	EOLS	-1.93	9.35	22.89
2025-09-12	EOLS	-1.93	9.35	22.89
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.3

Avg. EPS Est. Current Quarter

-0.16

Avg. EPS Est. Next Quarter

0.07

Insider Transactions

-1.93

Institutional Transactions

9.35

Beta

1.09

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

59.6

Max Drawdown 5-Year %

-68.4

Target Price

18.83

P/E

Forward P/E

25.28

PEG

P/S

1.67

P/B

P/Free Cash Flow

EPS

-0.97

Average EPS Est. Cur. Y

-0.55

EPS Next Y. (Est.)

0.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-22.31

Relative Volume

0.53

Return on Equity vs Sector %

307.5

Return on Equity vs Industry %

324.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.42

EBIT Estimation

61.6

Evolus, Inc. Common Stock

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 394

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

stock quote shares EOLS – Evolus, Inc. Stock Price stock today

news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EOLS – Evolus, Inc. yahoo finance google finance

stock history EOLS – Evolus, Inc. invest stock market

stock prices EOLS premarket after hours

ticker EOLS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EOLS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y